JAGSNPHARM Jagsonpal Pharmaceuticals Ltd Legal Disputes Announcement 2025 - Compliance Certificate Jagsonpal Pharmaceuticals Ltd has provided a compliance certificate according to Regulation 74(5) of SEBI for the quarter ending March 31, 2025, confirming the dematerialization of securities..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Jagsonpal Pharmaceuticals Ltd